In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

bioMerieux, Pierre Fabre merge; then part ways

Executive Summary

BioMerieux (in vitro diagnostics focusing on infectious diseases) and Pierre Fabre (pharmaceuticals for immunology, CNS, and the cardiovascular system; and dermo-cosmetics) merged to form bioMerieux-Pierre Fabre. The new enterprise will be equally owned by both of the originating companies.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition
    • Intra-Biotech Deal

Related Companies